Stay updated with breaking news from Launch Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- At the end of last year, argenx's Vyvgart (efgartigimod alfa-fcab) was approved by the FDA for the treatment of generalized myasthenia gravis...
/PRNewswire/ -- Impel's new entrant into the acute migraine landscape, the dihydroergotamine mesylate (DHE) nasal spray, Trudhesa, is off to a somewhat light...
/PRNewswire/ -- Impel's new entrant into the acute migraine landscape, the dihydroergotamine mesylate (DHE) nasal spray, Trudhesa, is off to a somewhat light...
/PRNewswire/ -- For those of us following the evolution of neurology pharmaceutical markets, 2021 will be remembered by many for the tumultuous roll out of...
/PRNewswire/ -- For those of us following the evolution of neurology pharmaceutical markets, 2021 will be remembered by many for the tumultuous roll out of...